IVANNA TSYKHULYAK: Open Payments
NPI 1083290423 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 99 payments from 16 companies in 2025. Trend: 2023 $604 · 2024 $1,500 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $328 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 19 | $206 |
| Viatris Specialty LLC | 10 | $135 |
| QOL Medical, LLC | 4 | $108 |
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Amgen Inc. | 3 | $56 |
| Antares Pharma, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 1 | $37 |
| Lundbeck LLC | 2 | $35 |
Products named: JARDIANCE, VRAYLAR, YUPELRI, Sucraid, QULIPTA, AIRSUPRA, OTEZLA, XYOSTED.
Industry payments across CT — which companies pay providers there.
